+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID05281757

International Post-Market Study Monitoring Safety and Performance of Ennovate4 Complex System in Scoliosis Patients

Led by Aesculap AG · Updated on 2026-06-02

200

Participants Needed

2

Research Sites

95 weeks

Total Duration

AI-Summary

What This Trial Is About

This research focuses on monitoring the safety and performance of the Ennovate Complex spinal system in patients with scoliosis and related spine deformities such as hyperkyphosis, hyperlordosis, congenital scoliosis, and neuromuscular scoliosis. It is a multicenter, multinational Post-Market Clinical Follow-Up PMCF study designed to collect detailed data on the use of this implant system as part of routine clinical practice without any intervention by the study team. The Ennovate Complex system is a device used for posterior stabilization and correction across multiple segments of the cervical and upper-thoracic spine. All patients treated with this system according to the official instructions for use are included in the study. The study involves prospective data collection that documents clinical and radiological outcomes related to this implant. Participants will be followed over approximately two years after surgery, with assessments before surgery and at multiple intervals postoperatively 3-4 months, 12 months, and 24 months. Researchers will track changes in pain, quality of life, daily functioning, and bone fusion as well as any side effects throughout the follow-up period. This extensive documentation aims to provide valuable information on the implants safety and performance for current and future patients.

CONDITIONS

Brief Title

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex

Research Team

S

Sarah Mattes

S

Stefan Maenz

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here